Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Melinjo Dimer Resveratrol can have Positive Effect Against Gout

Published: Monday, January 27, 2014
Last Updated: Monday, January 27, 2014
Bookmark and Share
Decreases serum uric acid levels in humans by increasing HDL cholesterol.

According to a clinical trial conducted by the Juntendo School of Medicine in Tokyo Japan, Melinjo Dimer Resveratrol decreases serum uric acid levels in humans.

This randomized controlled study demonstrated Melinjo Dimer Resveratrol beneficial effects in healthy adult males.

Compared with the placebo control, Melinjo Dimer Resvetarol significantly reduced serum uric acid levels and improved lipid metabolism by increasing HDL cholesterol.

The study was conducted by a group of scientist from the Juntendo School of Medicine in Tokyo. The study was double-blinded, randomized controlled study including 30 healthy males.

Compared with the placebo control, Melinjo Dimer Resvetarol significantly reduced serum uric acid levels and improved lipid metabolism by increasing HDL cholesterol.

Gout or the “rich man’s disease” has become more common in the recent years and is affecting about 1–2% of the Western population at some point in their lives. This rise is believed due to increasing risk factors in the population, such as metabolic syndrome, longer life expectancy and changes in diet and an increase in diseases associated with gout, such as high blood pressure. With the rising living standards globally gout has also become more common in other geographical areas, for example in China.

Gout is a medical condition characterized by acute inflammatory arthritis-a red, tender, hot, swollen joint. The most commonly affected joint is at the base of big toe; approximately 50% of cases are suffering of the podagra - “rich man’s disease in a poor man’s toe”.

Gout is caused by elevated levels of uric acid in the blood. The uric acid crystallizes, and the crystals deposit in joints, tendons, and surrounding tissues. Treatments are lifestyle changes and medical treatment with anti-inflammatory drugs.

Melinjo Dimer Resveratrol has demonstrated in previous trials its strong anti-inflammatory effect and this was the first human study demonstrating the positive effect on uric acid levels in humans.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!